David Leslie Szekeres insider trades

Open-market stock purchases and sales by David Leslie Szekeres, Director at GRI Bio, Inc, from SEC Form 4 filings since Oct 20, 2014.

Recent trades

No open-market trades in the last 12 months.

Companies traded

  • GRI GRI Bio, Inc: other filings, last Sep 18, 2025
  • HRTX Heron Therapeutics, Inc /de/: 2 sales, last Jul 13, 2023
  • RGLS Regulus Therapeutics Inc: other filings, last Dec 2, 2014

Get free alerts when David Leslie Szekeres files a new trade →